WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/7566
TitleThe 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary
Authors: Malhi, G. S.;Bell, E.;Singh, A. B.;Bassett, D.;Berk, M.;Boyce, P.;Bryant, R.;Gitlin, M.;Hamilton, A.;Hazell, P.;Hopwood, M.;Lyndon, B.;McIntyre, R. S.;Morris, G.;Mulder, R.;Porter, R.;Yatham, L. N.;Young, A.;Murray, G.
WSLHD Author: Boyce, Philip M.
Issue Date: 2020
Citation: Bipolar Disorders 22(8):788-804, 2020
Abstract: OBJECTIVES: To provide a succinct, clinically useful summary of the management of major depression, based on the 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (MDcpg2020).METHODS: To develop the MDcpg2020 , the mood disorders committee conducted an extensive review of the available literature to develop evidence-based recommendations (EBR) based on National Health and Medical Research Council (NHMRC) guidelines. In the MDcpg2020 , these recommendations sit alongside consensus-based recommendations (CBR) that were derived from extensive deliberations of the mood disorders committee, drawing on their expertise and clinical experience. This guideline summary is an abridged version that focuses on major depression. In collaboration with international experts in the field, it synthesises the key recommendations made in relation to the diagnosis and management of major depression.RESULTS: The depression summary provides a systematic approach to diagnosis, and a logical clinical framework for management. The latter begins with Actions, which include important strategies that should be implemented from the outset. These include lifestyle changes, psychoeducation and psychological interventions. The summary advocates the use of antidepressants in the management of depression as Choices and nominates seven medications that can be trialled as clinically indicated before moving to Alternatives for managing depression. Subsequent strategies regarding Medication include Increasing Dose, Augmenting and Switching (MIDAS). The summary also recommends the use of electroconvulsive therapy (ECT), and discusses how to approach non-response. CONCLUSIONS: The major depression summary provides up to date guidance regarding the management of major depressive disorder, as set out in the MDcpg2020. The recommendations are informed by research evidence in conjunction with clinical expertise and experience. The summary is intended for use by psychiatrists, psychologists and primary care physicians, but will be of interest to all clinicians and carers involved in the management of patients with depressive disorders.
URI: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/7566
DOI: https://dx.doi.org/10.1111/bdi.13035
Journal: Bipolar Disorders
Type: Journal Article
Study or Trial: Research Support, Non-U.S. Gov't
Review
Facility: Westmead
Keywords: Antidepressive Agents
Depressive Disorder, Major
Electroconvulsive Therapy
Mood Disorders
New Zealand
Appears in Collections:Westmead Hospital 2019 - 2024

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.